Vinzan secures latest Cultivation Partner for best-in-class GACP / EU GMP Cultivation, Processing and Export

BANGKOK, THAILAND, September 1, 2023/EINPresswire.com/ -- Leading Licensed Producer FYR Genetics (Thailand) Co., Ltd and prominent cannabis trading & marketing firm Vinzan have officially announced a strategic partnership with the construction of FYR's latest GACP / EU GMP compliant facility in Bangkok. Aimed at fostering best-in-class innovation, cultivation standards and export at scale, the new facility will also include a full service potency, contaminants and tissue culture laboratory.

This collaboration will leverage FYR's expertise while coupled with Vinzan's proven track record trading and marketing to Dispensaries across Thailand and bulk exports internationally. The partnership aims to drive sustainable growth and meet evolving market demands.

"We are excited to join forces with Vinzan as their latest Cultivation Partner in this transformative collaboration," said Matus Valent, CEO of FYR Genetics (Thailand) Co., Ltd. "This partnership represents a shared commitment to that goal and will shape the future of Thailand's Medical Cannabis Industry."

Khun Lucksipha Sirithawornsatit, Managing Director of Vinzan, shared similar sentiments. "Onboarding FYR is a remarkable opportunity to leverage our respective strengths and collectively contribute to Thailand's medical cannabis landscape."

Both companies are dedicated to innovation, sustainability and delivering top-quality cannabis products and laboratory services to the market.

KHUN WIPARAT PHARA
VINZAN (THAILAND) CO., LTD
+66 917819356
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.